Aura Biosciences

Company snapshot

Aura Biosciences is a clinical-stage biotechnology company focused on developing precision therapies for solid tumors that aim to preserve organ function. Our lead candidate, bel-sar (AU-011), is currently in late-stage development for early choroidal melanoma and in early-stage development in other ocular oncology indications and bladder cancer. Aura Biosciences is headquartered in Boston, MA. Ou

• 6 active pipeline program(s) linked via ClinicalTrials.gov.
• 17 US patent(s) indexed to this assignee profile.
• 6 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Aura Biosciences. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Aura Biosciences.

1. Jun 8, 2026 Clinical update

   AU-011-301 — Phase 3

2. May 26, 2026 Clinical update

   Bel-sar — Phase 3

3. May 23, 2026 Clinical update

   AU-011 — Phase 2

4. May 23, 2026 Clinical update

   AU-011 — Phase 2

5. May 23, 2026 Clinical update

   Light-activated AU-011 — Phase 2

View all clinical trial activity →

• What is Aura Biosciences?

  Aura Biosciences is a biotech organization headquartered in Boston, USA. It trades on NYSE under ticker AURA. Primary therapeutic focus areas include Uveal Melanoma, Choroidal Melanoma, Primary Indeterminate Lesions or Small Choroidal Melanoma, Eye Cancer, Non-muscle-invasive Bla

• Is Aura Biosciences publicly traded?

  Yes. Aura Biosciences is listed with ticker AURA on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Aura Biosciences develop or market?

  We link 3 drug profile(s) where Aura Biosciences is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/aura-biosciences#company-drugs.

• What are the latest developments for Aura Biosciences?

  In the last 12 months our linked public records show 6 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Aura Biosciences focus on?

  Aura Biosciences focuses on Uveal Melanoma, Choroidal Melanoma, Primary Indeterminate Lesions or Small Choroidal Melanoma based on our analysis of their pipeline programs and drug development activities.